Microcarrier Market - Growth, Trends, and Forecast (2019 - 2024)

The market is segmented by Material type, Application (Cell Therapy, Vaccine Manufacturing, Biologics Manufacturing, and Others), and Geography.

Market Snapshot

Microcarrier-1
Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

North America

Largest Market:

Asia Pacific

CAGR:

5.8%

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The microcarrier market is majorly driven by factors such as rising demand for cell-based vaccines and therapeutics, the rapid growth of biologics and biosimilar industry, and increasing R&D and availability of funding for cell therapy research.

Nearly a quarter of the current biologic pipeline is targeting the indications, which are small molecule dominated and have a large patient pool. This represents the trend of biologics entering non-traditional biologic disease areas, which could benefit from the increased therapeutic efficacy. Furthermore, this is also providing the room to the biosimilar market to grow.

In terms of medical efficacy, therapeutic spread, and population access biopharmaceuticals have vast potential, and much of this potential is still untapped. This potential can gradually be realized as manufacturing technologies, such as microcarrier based synthesis make progress, which may lead to commercialization of more effective therapies, increased manufacturing efficacy, and reduced therapy costs. Hence, owing to such rapid growth of the biologics and biosimilar industry, the market is positively affected.

Scope of the Report

A microcarrier is a support matrix, which allows the growth of adherent cells in bioreactors. In the large-scale commercial production of biologics and vaccines, microcarriers are employed to grow virus-generating or protein-producing adherent cell populations. As per the scope of the report, the microcarrier market includes various equipment and consumables, such as bioreactors, reagents, cell counters, and culture vessels in addition to microcarrier beads.

By Material Type
Alginate-Based
Collagen-Based
Dextran-Based
Polystyrene-Based
Others
By Application
Cell Therapy
Vaccine Manufacturing
Biologics Manufacturing
Other Applications
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cell Therapy is Expected to Show Fastest Growth in Application Segment

Microcarriers help in cost-effective cell production i.e they contribute to reducing fixed as well as variable costs during the large scale manufacturing. A few years back, it was suggested by the producers that microcarriers did not stand much helpful in cell production at a large scale as many of the microcarriers were made up of a solid matrix that required a microcarrier to be separated from the dissociated cells during downstream processing. This separation step was very complex and expensive previously.

However, with technological advancements, the current scenario has changed and the significance of microcarriers in cell therapy has increased. For instance, dissolvable microcarriers are currently there in the market that is composed of cross-linked polysaccharide polymers that can be efficiently dissolved during the cell harvest step. As the microcarriers get completely dissolved, there is no need for the separation and simply, the downstream process goes well. Therefore, these microcarriers are considered as beneficial beads for large scale cell production or cell therapy application.

Along with the above-mentioned statements, another factor that is responsible for the growth of cell therapy applications of microcarriers is that companies are currently focusing on the provision of microcarriers that contribute in the large scale and cost-effective production. E.g. Corning Incorporated provides dissolvable microcarriers.

Microcarrier-2

To understand key trends, Download Sample Report

North America is Expected to Dominate the Market

North America region is believed to have the largest share in the microcarrier market. This is majorly due to the rising gene and cell therapy research in the region along with the associations that are supporting this research. For instance, the American Society of Gene and Cell Therapy is responsible for the funding of the research and also, this society is forcing the biopharmaceutical and biotech companies to improve their R&D.

Along with that, the United States is witnessing high and rapid growth in the biologics and biosimilar Industry which is one of the major factor driving the microcarrier market in this region.

Microcarrier-3

To understand geography trends, Download Sample Report

Competitive Landscape

The Microcarrier market is mostly inclusive of the global players and few companies that are currently dominating the market include Thermo Fisher Scientific, Sartorius AG, Eppendorf AG, Danaher Corporation (Pall Corporation), and GE Healthcare. The competition in the market is expected to increase as new companies are also coming up in the market.

Major Players

  1. Thermo Fisher Scientific
  2. Merck KGaA
  3. Eppendorf AG
  4. Danaher Corporation
  5. GE Healthcare

* Complete list of players covered available in the table of contents below

Microcarrier-4

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Demand for Cell-based Vaccines and Therapeutics

      2. 4.2.2 Rapid Growth of Biologics and Biosimilar Industry

      3. 4.2.3 Increasing R&D and Availability of Funding for Cell Therapy Research

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Biologics and Cell-based Therapies

      2. 4.3.2 Growth Limitations of High Density Microcarrier Cultures

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Material Type

      1. 5.1.1 Alginate-Based

      2. 5.1.2 Collagen-Based

      3. 5.1.3 Dextran-Based

      4. 5.1.4 Polystyrene-Based

      5. 5.1.5 Others

    2. 5.2 By Application

      1. 5.2.1 Cell Therapy

      2. 5.2.2 Vaccine Manufacturing

      3. 5.2.3 Biologics Manufacturing

      4. 5.2.4 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 US

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 UK

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Danaher Corporation

      2. 6.1.2 Eppendorf AG

      3. 6.1.3 GE Healthcare

      4. 6.1.4 Lonza Group AG

      5. 6.1.5 Merck KGaA

      6. 6.1.6 Thermo Fisher Scientific Inc.

      7. 6.1.7 Hi-Media Laboratories

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information